These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 39001439)

  • 1. Chromogenic
    Papaleo N; Molina-Alvarez A; Onieva R; Fuertes D; Sanchez-Gonzalez B; Riera X; Lopez-Segura D; Lome-Maldonado C; Ara-Mancebo X; Yelamos J; Salido M; Vazquez I; Calvo X; Colomo L
    Cancers (Basel); 2024 Jun; 16(13):. PubMed ID: 39001439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas.
    Vazquez I; Papaleo N; Garcia E; Salido M; Salar A; Hernandez S; Calvo X; Colomo L
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.
    Colomo L; Vazquez I; Papaleo N; Espinet B; Ferrer A; Franco C; Comerma L; Hernandez S; Calvo X; Salar A; Climent F; Mate JL; Forcada P; Mozos A; Nonell L; Martinez A; Carrio A; Costa D; Dlouhy I; Salaverria I; Martin-Subero JI; Lopez-Guillermo A; Valera A; Campo E;
    Am J Surg Pathol; 2017 Jul; 41(7):877-886. PubMed ID: 28288039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas.
    Rimsza LM; Day WA; McGinn S; Pedata A; Natkunam Y; Warnke R; Cook JR; Marafioti T; Grogan TM
    Diagn Pathol; 2014 Jul; 9():144. PubMed ID: 25047073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of LMO2 in Hodgkin, Burkitt and germinal center diffuse large B cell lymphomas.
    Shams TM
    J Egypt Natl Canc Inst; 2011 Dec; 23(4):147-53. PubMed ID: 22776842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score.
    Tekin N; Omidvar N; Morris TP; Conget P; Bruna F; Timar B; Gagyi E; Basak R; Naik O; Auewarakul C; Sritana N; Levy D; Cerci JJ; Bydlowski SP; Pereira J; Dimamay MP; Natividad F; Chung JK; Belder N; Kuzu I; Paez D; Dondi M; Carr R; Ozdag H; Padua RA
    Oncotarget; 2016 Dec; 7(50):83319-83329. PubMed ID: 27825111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
    Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA
    Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of expression of LMO2 clone SP51 identifies MYC rearrangements in aggressive large B-cell lymphomas.
    Vazquez I; Papaleo N; Lop J; Puiggros A; Sanchez-Gonzalez B; Diez-Feijoo R; Gimeno E; Andrade-Campos M; Salar A; Espinet B; Salido M; Tapia G; Carreras J; Ferrer A; Arenillas L; Calvo X; Colomo L
    Virchows Arch; 2021 Dec; 479(6):1073-1078. PubMed ID: 33811533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.
    Natkunam Y; Zhao S; Mason DY; Chen J; Taidi B; Jones M; Hammer AS; Hamilton Dutoit S; Lossos IS; Levy R
    Blood; 2007 Feb; 109(4):1636-42. PubMed ID: 17038524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromogenic In Situ Hybridization (CISH) as a Method for Detection of C-Myc Amplification in Formalin-Fixed Paraffin-Embedded Tumor Tissue: An Update.
    Todorović-Raković N
    Methods Mol Biol; 2021; 2318():313-320. PubMed ID: 34019299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of LMO2 is associated with t(14;18)/IGH-BCL2 fusion but not BCL6 translocations in diffuse large B-cell lymphoma.
    Durnick DK; Law ME; Maurer MJ; Natkunam Y; Levy R; Lossos IS; Kurtin PJ; McPhail ED
    Am J Clin Pathol; 2010 Aug; 134(2):278-81. PubMed ID: 20660332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of GCET1, HGAL (GCET2), and LMO2 in the Determination of Germinal Center Phenotype in Diffuse Large B-cell Lymphoma.
    Berker N; Yeğen G; Özlük Y; Doğan Ö
    Turk J Haematol; 2023 Aug; 40(3):162-173. PubMed ID: 37519110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
    Natkunam Y; Farinha P; Hsi ED; Hans CP; Tibshirani R; Sehn LH; Connors JM; Gratzinger D; Rosado M; Zhao S; Pohlman B; Wongchaowart N; Bast M; Avigdor A; Schiby G; Nagler A; Byrne GE; Levy R; Gascoyne RD; Lossos IS
    J Clin Oncol; 2008 Jan; 26(3):447-54. PubMed ID: 18086797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromogenic in situ hybridization is a reliable assay for detection of ALK rearrangements in adenocarcinomas of the lung.
    Schildhaus HU; Deml KF; Schmitz K; Meiboom M; Binot E; Hauke S; Merkelbach-Bruse S; Büttner R
    Mod Pathol; 2013 Nov; 26(11):1468-77. PubMed ID: 23743932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma.
    Valentino C; Kendrick S; Johnson N; Gascoyne R; Chan WC; Weisenburger D; Braziel R; Cook JR; Tubbs R; Campo E; Rosenwald A; Ott G; Delabie J; Jaffe E; Zhang W; Brunhoeber P; Nitta H; Grogan T; Rimsza L
    Am J Clin Pathol; 2013 Feb; 139(2):242-54. PubMed ID: 23355209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 17. [Establishment and Clinical Significance of Prognostic Nomogram Model for Diffuse Large B-Cell Lymphoma Based on Immunohistochemistry Markers and International Prognostic Index Scores].
    Xu YW; Zhou YL; Kong FC; Chen ZW; Li F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):753-761. PubMed ID: 37356936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of c-myc amplification in formalin-fixed paraffin-embedded tumor tissue by chromogenic in situ hybridization (CISH).
    Todorović-Raković N
    Methods Mol Biol; 2013; 1012():249-54. PubMed ID: 24006070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of immunoglobulin light-chain restriction in cutaneous B-cell lymphomas by ultrasensitive bright-field mRNA in situ hybridization.
    Minca EC; Wang H; Wang Z; Lanigan C; Billings SD; Luo Y; Tubbs RR; Ma XJ
    J Cutan Pathol; 2015 Feb; 42(2):82-9. PubMed ID: 25363373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.
    Cubedo E; Gentles AJ; Huang C; Natkunam Y; Bhatt S; Lu X; Jiang X; Romero-Camarero I; Freud A; Zhao S; Bacchi CE; Martínez-Climent JA; Sánchez-García I; Melnick A; Lossos IS
    Blood; 2012 Jun; 119(23):5478-91. PubMed ID: 22517897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.